These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 22371247)

  • 1. Pathogenesis of membranous nephropathy: recent advances and future challenges.
    Ronco P; Debiec H
    Nat Rev Nephrol; 2012 Feb; 8(4):203-13. PubMed ID: 22371247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-phospholipase A2 receptor antibodies and the pathogenesis of membranous nephropathy.
    Ronco P; Debiec H
    Nephron Clin Pract; 2014; 128(3-4):232-7. PubMed ID: 25401774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Idiopathic and secondary membranous nephropathies].
    Ronco P; Debiec H
    Presse Med; 2012 Mar; 41(3 Pt 1):290-7. PubMed ID: 22208961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-NEP and anti-PLA2R antibodies in membranous nephropathy: an update].
    Pozdzik AA; Debiec H; I Brochériou ; Husson C; Rorive S; Broeders N; Le Moine A; Ronco P; Nortier J
    Rev Med Brux; 2015; 36(3):166-71. PubMed ID: 26372979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Membranous nephropathy: A fairy tale for immunopathologists, nephrologists and patients.
    Ronco P; Debiec H
    Mol Immunol; 2015 Nov; 68(1):57-62. PubMed ID: 26597209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunology of membranous nephropathy: from animal models to humans.
    Sinico RA; Mezzina N; Trezzi B; Ghiggeri GM; Radice A
    Clin Exp Immunol; 2016 Feb; 183(2):157-65. PubMed ID: 26459770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy.
    Stanescu HC; Arcos-Burgos M; Medlar A; Bockenhauer D; Kottgen A; Dragomirescu L; Voinescu C; Patel N; Pearce K; Hubank M; Stephens HA; Laundy V; Padmanabhan S; Zawadzka A; Hofstra JM; Coenen MJ; den Heijer M; Kiemeney LA; Bacq-Daian D; Stengel B; Powis SH; Brenchley P; Feehally J; Rees AJ; Debiec H; Wetzels JF; Ronco P; Mathieson PW; Kleta R
    N Engl J Med; 2011 Feb; 364(7):616-26. PubMed ID: 21323541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of PLA2R1 and HLA-DQA1 sequence variants in Japanese patients with idiopathic and secondary membranous nephropathy.
    Kaga H; Komatsuda A; Omokawa A; Okuyama S; Mori K; Wakui H; Takahashi N
    Clin Exp Nephrol; 2018 Apr; 22(2):275-282. PubMed ID: 28849274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA-DQA1 and PLA2R1 polymorphisms and risk of idiopathic membranous nephropathy.
    Bullich G; Ballarín J; Oliver A; Ayasreh N; Silva I; Santín S; Díaz-Encarnación MM; Torra R; Ars E
    Clin J Am Soc Nephrol; 2014 Feb; 9(2):335-43. PubMed ID: 24262501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between PLA2R1 and HLA-DQA1 variants associates with anti-PLA2R antibodies and membranous nephropathy.
    Lv J; Hou W; Zhou X; Liu G; Zhou F; Zhao N; Hou P; Zhao M; Zhang H
    J Am Soc Nephrol; 2013 Jul; 24(8):1323-9. PubMed ID: 23813219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membranous nephropathy: the start of a paradigm shift.
    Herrmann SM; Sethi S; Fervenza FC
    Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):203-10. PubMed ID: 22240444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen identification in membranous nephropathy moves toward targeted monitoring and new therapy.
    Ronco P; Debiec H
    J Am Soc Nephrol; 2010 Apr; 21(4):564-9. PubMed ID: 20185638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Pathogenesis of Membranous Nephropathy.
    Ronco P; Debiec H
    Annu Rev Pathol; 2020 Jan; 15():287-313. PubMed ID: 31622560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Membranous nephropathy: up to date].
    Imai E
    Nihon Jinzo Gakkai Shi; 2011; 53(5):692-6. PubMed ID: 21842602
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction between PLA2R1 and HLA-DQA1 variants contributes to the increased genetic susceptibility to membranous nephropathy in Western China.
    Wang W; Fan S; Li G; Wang AY; Hong D; Zhong X; Wang L
    Nephrology (Carlton); 2019 Sep; 24(9):919-925. PubMed ID: 30467913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy.
    Kanigicherla D; Gummadova J; McKenzie EA; Roberts SA; Harris S; Nikam M; Poulton K; McWilliam L; Short CD; Venning M; Brenchley PE
    Kidney Int; 2013 May; 83(5):940-8. PubMed ID: 23364522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenesis of membranous nephropathy: update.
    Kwatra IS; Prasher PK
    J Assoc Physicians India; 2013 Nov; 61(11):807-10. PubMed ID: 24974493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies specific for the phospholipase A2 receptor in recurrent and De Novo membranous nephropathy.
    Debiec H; Martin L; Jouanneau C; Dautin G; Mesnard L; Rondeau E; Mousson C; Ronco P
    Am J Transplant; 2011 Oct; 11(10):2144-52. PubMed ID: 21827616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Pathogenesis of Membranous Nephropathy: Focus on PLA2R1 and Its Role.
    Liu W; Gao C; Dai H; Zheng Y; Dong Z; Gao Y; Liu F; Zhang Z; Liu Z; Liu W; Liu B; Liu Q; Shi J
    Front Immunol; 2019; 10():1809. PubMed ID: 31447839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Progress in Deciphering the Etiopathogenesis of Primary Membranous Nephropathy.
    Kronbichler A; Oh J; Meijers B; Mayer G; Shin JI
    Biomed Res Int; 2017; 2017():1936372. PubMed ID: 28904948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.